Anteris Technologies Global Corp. (NASDAQ: AVR) appointed Brent Moen as chief financial officer effective September 11, 2026, with an annual base salary of $475,000. Matthew McDonnell will leave the CFO role on the same date and begin serving as the company’s Head of Australia.
Azitra, Inc. (AMEX: AZTR) will present updates on its ATR-COSF and ATR-04 programs at an investor conference beginning September 14, 2026.
Belite Bio, Inc. (NASDAQ: BLTE) submitted a Japanese New Drug Application for tinlarebant to treat Stargardt disease type 1, a rare inherited retinal disorder affecting an estimated 9,500 people in Japan. The application seeks review under Japan’s Sakigake system, which is designed to accelerate …
BioNTech SE (NASDAQ: BNTX) Chief Executive Officer Sahin Ugur sold 76,500 shares across two transactions.
Exclusive Federal Access and Commercial Terms
Deep TMS Study Records Depression Outcomes
BridgeBio Oncology Therapeutics, Inc. (NASDAQ: BBOT) is prioritizing BBO-8520 with pembrolizumab for 2L+ KRAS G12C inhibitor-experienced NSCLC after the combination produced a 75% ORR at the 500 mg QD dose.
PEABODY ENERGY CORP (NYSE: BTU) awarded 130 shares to executive vice president and chief operating officer Yeates Darren Ronald at $27.64 per share. The transaction was dated September 3, 2026, and left Yeates with reported ownership of 130,498 shares.
PEABODY ENERGY CORP (NYSE: BTU) awarded director Robert A Malone 52 shares at $27.64 per share.
BIO-KEY International Inc. (NASDAQ: BKYI) adjourned its 2026 annual meeting after stockholders did not have enough votes to approve issuance of up to 1,236,668 common shares upon exercise of warrants. The proposals remain unchanged.